Skip to content

Clinical Study of Impact of Different Pacing Site in Patients

Clinical Study of Impact of Different Pacing Site in Patients

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04931550
Enrollment
600
Registered
2021-06-18
Start date
2020-08-01
Completion date
2026-12-31
Last updated
2023-01-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bradyarrhythmias, Heart Failure, Pacemaker

Brief summary

At present, cardiac pacing has been widely used in the treatment of bradyarrhythmias and heart failure, which can effectively improve the survival rate of patients. With the rapid development of technology, different sites can be chosen to pace, such as right atrial appendage, the atrial septum and the right atrial wall in the atrium, His bundle, left bundle branch area, right ventricular apex, outflow tract, and left ventricular pacing via coronary vein in the ventricle. There are few studies comparing the long-term efficacy and safety of different pacing sites in daily practice. This study aims to observe the efficacy and safety of cardiac pacing at different sites in short and long term, and to compare the advantages and disadvantages of pacing at different sites.

Interventions

DEVICEPacemaker implantation

Different pacing sites will be chosen according to the patients condition.

Sponsors

Second Affiliated Hospital, School of Medicine, Zhejiang University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 100 Years
Healthy volunteers
No

Inclusion criteria

* Patients who received pacemaker implantation in the Second Hospital of Zhejiang Medical University by Pan Xiaohong and other surgeons. * Patients who have the ability to understand the test and can cooperate with investigators.

Exclusion criteria

* Patients who unable to understand or unwilling to fill in informed consent forms or follow visitors.

Design outcomes

Primary

MeasureTime frameDescription
Composite of Cardiovascular death, myocardial infarction, and stroke events60 monthsComposite of Cardiovascular death, myocardial infarction, and stroke events in 60 months

Countries

China

Contacts

Primary ContactXiaohong Pan
heartpanxh@zju.edu.cn+8613857116993

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026